BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1413846)

  • 1. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.
    Ito Y; Fujimoto Y; Obara T
    World J Surg; 1992; 16(4):759-63; discussion 763-4. PubMed ID: 1413846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and conjugated plasma catecholamines in pheochromocytoma patients with and without sustained hypertension.
    Puyó AM; Levin GM; Armando I; Barontini MB
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):111-7. PubMed ID: 3766042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet norepinephrine and epinephrine concentration in patients with pheochromocytoma.
    Berent H; Uchman B; Wocial B; Januszewicz W
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):618-21. PubMed ID: 2222953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytomas: tendency to degenerate and cause paroxysmal hypertension.
    Ito Y; Obara T; Yamashita T; Kanbe M; Iihara M
    World J Surg; 1996 Sep; 20(7):923-6; discussion 927. PubMed ID: 8678972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. Its relation to hypertension.
    Puyo A; Levin G; Armando I; Barontini M
    Hypertension; 1988 Feb; 11(2 Pt 2):I202-6. PubMed ID: 3346058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel inhibition in pheochromocytoma.
    Favre L; Forster A; Fathi M; Vallotton MB
    Acta Endocrinol (Copenh); 1986 Nov; 113(3):385-90. PubMed ID: 3788414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma dopamine in patients presenting with the pseudopheochromocytoma quandary: retrospective analysis of 10 years' experience.
    Kuchel O
    J Hypertens; 1998 Oct; 16(10):1531-7. PubMed ID: 9814626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of dopa in phaeochromocytoma.
    Louis WJ; Doyle AE; Heath WC; Robinson MJ
    Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma atrial natriuretic factor in catecholamine-producing tumor patients.
    Puyó AM; Levin GM; Armando I; Donoso AS; Fernández BE; Barontini MB
    Clin Exp Hypertens; 1999 Oct; 21(7):1129-44. PubMed ID: 10513832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catecholamine-producing tumors].
    Chávez Lara B
    Arch Inst Cardiol Mex; 1991; 61(6):553-9. PubMed ID: 1793308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating catecholamine and glucagon responses to insulin-induced blood glucose decrement in a patient with pheochromocytoma.
    Bolli G; De Feo P; Massi-Benedetti M; Compagnucci P; Cartechini MG; Santeusanio F; Brunetti P
    J Clin Endocrinol Metab; 1982 Feb; 54(2):447-9. PubMed ID: 7033279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pheochromocytoma and hypophysectomy on blood pressure and catecholamines in NEDH rats.
    Manger WM; Hulse MC; Forsyth MS; Chute RN; Brown CE; Webb K; Sussman R; Warren S
    Hypertension; 1982; 4(3 Pt 2):200-7. PubMed ID: 7068205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma.
    Sinclair D; Shenkin A; Lorimer AR
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():417-9. PubMed ID: 1892355
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma catecholamine changes during excision of pheochromocytoma.
    Newell KA; Prinz RA; Brooks MH; Glisson SN; Barbato AL; Freeark RJ
    Surgery; 1988 Dec; 104(6):1064-73. PubMed ID: 3194833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
    Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic hyperreflexia and its differentiation from pheochromocytoma.
    Manger WM; Davis SW; Chu DS
    Arch Phys Med Rehabil; 1979 Apr; 60(4):159-61. PubMed ID: 475568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of plasma catecholamine. Effects of glucagon administration].
    Conte-Devolx B; Oliver C; Orlando M; Aquaron R; Giraud P; Gillioz P; Amabile G; Henry JF; Daheme D; Codaccioni JL; Serradimigni A
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():85-9. PubMed ID: 6810834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
    Zweifler AJ; Julius S
    N Engl J Med; 1982 Apr; 306(15):890-4. PubMed ID: 7062972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catecholamines in the cardiovascular expression of pheochromocytoma. II--Study of free urinary catecholamines in 14 pheochromocytomas. Classification of pheochromocytomas according to type of secretion].
    Fontaine P; Wemeau JL; Verlet E; Racadot-Leroy N; Decaudaveine B; Proye C; Lefebvre J; Fossati P
    Ann Endocrinol (Paris); 1986; 47(5):380-8. PubMed ID: 3827193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.